JP2017533920A5 - - Google Patents

Download PDF

Info

Publication number
JP2017533920A5
JP2017533920A5 JP2017524349A JP2017524349A JP2017533920A5 JP 2017533920 A5 JP2017533920 A5 JP 2017533920A5 JP 2017524349 A JP2017524349 A JP 2017524349A JP 2017524349 A JP2017524349 A JP 2017524349A JP 2017533920 A5 JP2017533920 A5 JP 2017533920A5
Authority
JP
Japan
Prior art keywords
cancer
situ vaccine
mosaic virus
cowpea mosaic
empty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017524349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017533920A (ja
JP6731405B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/059675 external-priority patent/WO2016073972A1/en
Publication of JP2017533920A publication Critical patent/JP2017533920A/ja
Publication of JP2017533920A5 publication Critical patent/JP2017533920A5/ja
Application granted granted Critical
Publication of JP6731405B2 publication Critical patent/JP6731405B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017524349A 2014-11-07 2015-11-09 ウイルス粒子を用いた癌免疫療法 Active JP6731405B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462076543P 2014-11-07 2014-11-07
US62/076,543 2014-11-07
US201562107617P 2015-01-26 2015-01-26
US62/107,617 2015-01-26
US201562159389P 2015-05-11 2015-05-11
US62/159,389 2015-05-11
PCT/US2015/059675 WO2016073972A1 (en) 2014-11-07 2015-11-09 Cancer immunotherapy using virus particles

Publications (3)

Publication Number Publication Date
JP2017533920A JP2017533920A (ja) 2017-11-16
JP2017533920A5 true JP2017533920A5 (enExample) 2018-11-22
JP6731405B2 JP6731405B2 (ja) 2020-07-29

Family

ID=55909946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017524349A Active JP6731405B2 (ja) 2014-11-07 2015-11-09 ウイルス粒子を用いた癌免疫療法

Country Status (7)

Country Link
US (4) US10639363B2 (enExample)
EP (2) EP3215520B1 (enExample)
JP (1) JP6731405B2 (enExample)
CN (1) CN107001428B (enExample)
AU (1) AU2015342790B2 (enExample)
CA (1) CA2967336C (enExample)
WO (2) WO2016073972A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10086095B2 (en) 2012-10-09 2018-10-02 Case Western Reserve University Rod-shaped plant virus nanoparticles as imaging agent platforms
WO2014113203A1 (en) 2013-01-17 2014-07-24 Case Western Reserve University Viral nanoparticle multimers
US11998594B2 (en) 2014-04-02 2024-06-04 Case Western Reserve University Anti-cancer plant virus particles linked to HER2 antigens
US9925281B2 (en) 2014-08-05 2018-03-27 Case Western Reserve University Coated plant virus imaging agents
US11617787B2 (en) 2014-11-07 2023-04-04 Case Western Reserve University Cancer immunotherapy using virus particles
US12465624B2 (en) 2018-05-08 2025-11-11 Case Western Reserve University Cancer immunotherapy using virus particles and immune checkpoint therapy
EP3215520B1 (en) 2014-11-07 2022-01-05 Case Western Reserve University Cancer immunotherapy using virus particles
US10624975B2 (en) 2015-06-29 2020-04-21 Case Western Reserve University Anticancer drug-containing plant virus particles
EP3322485B1 (en) 2015-07-16 2020-07-01 Case Western Reserve University Plant virus particles for delivery of antimitotic agents
US11433123B2 (en) 2016-07-21 2022-09-06 Case Western Reserve University Sustained release cowpea mosaic virus or virus-like particle therapeutic constructs for the treatment of cancer
WO2018085658A1 (en) 2016-11-03 2018-05-11 Case Western Reserve University Melt processed viral nanoparticle constructs
US12433840B2 (en) 2016-11-03 2025-10-07 Case Western Reserve University Melt processed viral nanoparticle constructs
US11590183B2 (en) 2017-03-10 2023-02-28 Case Western Reserve University Cancer immunotherapy using virus particles
WO2018213587A1 (en) 2017-05-17 2018-11-22 Case Western Reserve University Anticancer trail-targeted plant virus particles
WO2019084555A1 (en) 2017-10-27 2019-05-02 Case Western Reserve University TYMOVIRUS VIRUSES AND VIRAL TYPE PARTICLES USEFUL AS NANOVECTORS FOR IMAGING AND THERAPEUTIC AGENTS
WO2019173487A1 (en) * 2018-03-06 2019-09-12 University Of Louisville Research Foundation, Inc. Methods for treatment of cancer and enhancement of nanoparticle accumulation in tissues
CN113396155A (zh) * 2018-12-27 2021-09-14 维伊木恩股份有限公司 偶联病毒样颗粒及其作为抗肿瘤免疫重定向剂的用途
WO2020180738A1 (en) * 2019-03-01 2020-09-10 The Regents Of The University Of California Cancer immunotherapy
US11390853B2 (en) 2019-04-26 2022-07-19 Case Western Reserve University Freeze dried viral nanoparticle constructs
US11896676B2 (en) 2019-08-07 2024-02-13 Case Western Reserve University Targeting cancer cells and tissue using filamentous plant virus particles
CN110859861A (zh) * 2019-12-04 2020-03-06 武汉工程大学 植物病原微生物杀灭癌细胞或艾滋病病毒的用途
US11529430B2 (en) 2019-12-20 2022-12-20 Case Western Reserve University Polydopamine decorated tobacco mosaic theranostic virus nanoparticles
US12203073B2 (en) 2019-12-20 2025-01-21 Case Western Reserve University Plant viral RNA delivery nanoparticles and uses thereof
US20240066108A1 (en) * 2021-01-08 2024-02-29 The Regents Of The University Of California Ovarian cancer vaccine
JP2025504361A (ja) * 2022-01-19 2025-02-12 ウニベルズィテート ベルン ウイルス様粒子と微結晶性チロシンとの組成物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004606A (en) 1986-09-24 1991-04-02 Hybritech Incorporated Non-covalent antibody-anthracycline immunocomplexes
GB9921337D0 (en) * 1999-09-09 1999-11-10 Axis Genetics Plc Modified plant viruses
GB9924351D0 (en) * 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
PT2371392E (pt) 2002-05-02 2015-10-07 Wyeth Holdings Llc Conjugados de derivado da caliqueamicina - transportador
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung
US20070248617A1 (en) 2004-06-02 2007-10-25 Bachmann Martin F Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
WO2008048288A2 (en) 2005-11-09 2008-04-24 Montana State University Novel nanoparticles and use thereof
WO2008085147A2 (en) * 2005-12-02 2008-07-17 Dow Global Technologies Inc. Novel plant virus particles and methods of inactivation thereof
US7771339B2 (en) * 2006-05-31 2010-08-10 Ab Mimator Method and system for radiotherapy treatment
US20100183504A1 (en) 2007-06-14 2010-07-22 Fanqing Frank Chen Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
WO2016149264A1 (en) 2015-03-18 2016-09-22 The Johns Hopkins University Compositions and methods for sensitizing cells to trail-induced apoptosis
DK2327764T3 (da) * 2009-11-30 2012-04-02 United Cancer Res Inst Ny klon af Newcastle disease-virus, dens fremstilling og dens anvendelse ved medicinsk behandling af cancer
WO2012078069A1 (en) 2010-12-09 2012-06-14 Iosif Grigorievich Atabekov Spherical nano- and microparticles derived from plant viruses for the display of foreign proteins or epitopes
JP5799294B2 (ja) 2011-07-29 2015-10-21 株式会社ユーテック 強誘電体膜
WO2013158620A1 (en) 2012-04-16 2013-10-24 North Carolina State University Nanotechnology system for agricultural applications
DK2841097T3 (da) 2012-04-24 2022-11-28 Ohio State Innovation Foundation Sammensætninger og fremgangsmåder til behandling og forebyggelse af porcint reproduktions- og respirationssyndrom
US10232057B2 (en) 2012-05-31 2019-03-19 Case Western Reserve University Targeting cancer cells and tissue using filamentous plant virus particles
US10086095B2 (en) 2012-10-09 2018-10-02 Case Western Reserve University Rod-shaped plant virus nanoparticles as imaging agent platforms
JP2016531927A (ja) * 2013-09-19 2016-10-13 フォリア バイオテック インコーポレイテッド 癌治療でのパパイヤモザイクウイルス及びウイルス様粒子
WO2015188110A1 (en) 2014-06-05 2015-12-10 The Johns Hopkins University Reversible pegylation for screeing of therapeutic proteins in vivo
DK3174976T3 (da) 2014-08-01 2020-11-23 Gpb Scient Inc Fremgangsmåder og systemer til forarbejdning af partikler
US9925281B2 (en) 2014-08-05 2018-03-27 Case Western Reserve University Coated plant virus imaging agents
EP3215520B1 (en) * 2014-11-07 2022-01-05 Case Western Reserve University Cancer immunotherapy using virus particles
US10624975B2 (en) * 2015-06-29 2020-04-21 Case Western Reserve University Anticancer drug-containing plant virus particles
EP3322485B1 (en) 2015-07-16 2020-07-01 Case Western Reserve University Plant virus particles for delivery of antimitotic agents
WO2018213587A1 (en) 2017-05-17 2018-11-22 Case Western Reserve University Anticancer trail-targeted plant virus particles

Similar Documents

Publication Publication Date Title
JP2017533920A5 (enExample)
Araste et al. Peptide-based targeted therapeutics: Focus on cancer treatment
Beloqui et al. Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier
HRP20211177T1 (hr) Korteksolon 17alfa-valerat za uporabu u liječenju tumora
WO2016004048A3 (en) Targeted conjugates and particles and formulations thereof
WO2016161342A3 (en) Nitrobenzyl derivatives of anti-cancer agents
JP2015516989A5 (enExample)
WO2015095227A3 (en) Peptidomimetic compounds and antibody-drug conjugates thereof
NZ710746A (en) Pyrrolobenzodiazepines and conjugates thereof
JP2011079858A5 (enExample)
WO2017194782A3 (en) Therapeutic targeting of non-cellular structures
EP3686200A3 (en) Bicyclic heterocycle compounds and their uses in therapy
JP2015500225A5 (enExample)
CN112888458A (zh) Cldn18的抗体和化疗药物的联合治疗
JP2015502926A5 (enExample)
JP2016528217A5 (enExample)
JP2017508724A5 (enExample)
JP2014506233A5 (enExample)
MX381016B (es) Composiciones de nanopartículas para su uso en la entrega de una carga útil al cerebro.
JP2013533269A5 (enExample)
RU2017141536A (ru) Замещенные производные индол-5-ола и их терапевтические применения
JP2016526021A5 (enExample)
JP2015506352A5 (enExample)
JP2021505669A5 (enExample)
JP2013100286A5 (enExample)